Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial Spasm

NCT01564979 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2012-03-28

No results posted yet for this study

Summary

The purpose of this study is to determine whether pretarsal and preseptal techniques of Botulinum toxin type A injection have any effect on tear functions.

Conditions

  • Hemifacial Spasm

Interventions

DRUG

preseptal injection of botulinum toxin type A

botulinum toxin type A (Botox)2.5 units, 5 points

DRUG

pretarsal injection of Botulinum toxin type A

Botulinum toxin type A 2,5 units, 5 points

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • kitthisak kithaweesin, MD · Khon Kaen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-09-30
Completion
2012-12-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01564979 on ClinicalTrials.gov